Phase 1 Pharmacology

BioKinetic Europe was founded in 1996 as an independent Phase 1 Clinical Pharmacology company by Managing Director Moira Burke and Medical Director David Bell. Since then they’ve overseen the company's growth and strategic development and today the company employs over 25 highly qualified staff.

BioKinetic Europe has developed a reputation for meticulously managed Phase I – II studies on behalf of pharmaceutical companies in Europe, Japan and the United States.

The company's core competency is in the conduct of Phase 1 Clinical Pharmacology studies.